[Systemic antifungals. Pharmacodynamics and pharmacokinetics]. / Antifúngicos sistémicos. Farmacodinamia y farmacocinética.
Rev Iberoam Micol
; 23(1): 39-49, 2006 Mar.
Article
em Es
| MEDLINE
| ID: mdl-16499430
ABSTRACT
Invasive fungal infections are important causes of morbidity and mortality in critically ill non neutropenic patients. For many years, amphotericin B and flucytosine have been the only available antifungal agents for invasive fungal infections. Fortunately, the antifungal armamentarium has increased during the past two decades with the addition of several new agents. In addition to itraconazole and fluconazole, lipid formulations of amphotericin B, voriconazole, and caspofungin have been recently licensed. These various antifungal agents differ in their pharmacokinetic and pharmacodynamic profile.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Antifúngicos
Idioma:
Es
Ano de publicação:
2006
Tipo de documento:
Article